Various direct-to-practitioner and ‘alternative’ sample-distribution methods are coming along, but delivery via the rep continues
At the just concluded PDMA Sharing Conference (San Antonio, Sept. 25-29), the PDMA Alliance (www.pdmaaliance.org), event sponsor, together with TGaS Advisors, a consulting firm, presented results of a recent survey of members, who are primarily sample-accountability and PDMA compliance professionals at manufacturers. Respondents are mostly satisfied with their current preferences and capabilities: 74% said that they weren’t planning changes in their processes. But among the remainder, a range of options are being considered: a third are planning to convert to 100% direct-to-practitioner (DTP) methods; 22% are planning the opposite—100% hand-carried delivery (i.e., delivered by reps). The remainder plan a mix of DTP, hand and alternative techniques.
For respondents who are contemplating expanded DTP methods, TGaS captured data that essentially rank these alternatives by popularity. The options being considered are: use of business-reply cards (78%); telesampling (63%—i.e., phone-based offers); e-sampling, making use of physician-frequented websites or online services, will be tried by 44% of respondents, and video detailing (a combination of online video and live telecommunications) will be tried by 22%.
Options are also expanding in how sample or financial-assistance programs are being offered to consumers. 90% of respondents use coupons;76% use vouchers; 24% use a pre-paid card; and 17% offer co-pay assistance.
The full PDMA Alliance/TGaS study is available to Alliance members via the organization’s website.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.